Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: DNA Damage and ROS1[original query] |
---|
Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients. European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma. Frontiers in oncology 2021 7 11 666145. Ma Si-Cong, Zhu Hong-Bo, Wang Jian, Zhang Yan-Pei, Guo Xue-Jun, Long Li-Li, Guo Ze-Qin, Wu De-Hua, Dong Zhong-Yi, Bai X |
Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in pharmacology 2021 6 12 645862. Wen Yang, Lin Anqi, Zhu Weiliang, Wei Ting, Luo Peng, Guo Linlang, Zhang Ji |
Genomic features of Chinese small cell lung cancer. BMC medical genomics 2022 May 15 (1): 117. Liu Jun, Zhao Zhuxiang, Wei Shuquan, Li Binkai, Zhao Ziw |
Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma. Journal of Cancer 2022 4 13 (5): 1565-1572. Wu Xiaonan, Zhao Jun, Yang Ling, Nie Xin, Wang Zheng, Zhang Ping, Li Chao, Hu Xueqing, Tang Min, Yi Yuting, Du Xinhua, Xia Xuefeng, Guan Yanfang, Yu Zicheng, Gu Wenguang, Quan Xiangming, Li Lin, Shi Ho |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: